In 2023, Cardiovascular System Medicine sales in Italy stood at 3.37 billion USD. From this baseline, the forecast for 2024 indicates a decline to 3.19 billion USD, marking a year-on-year decrease. Similarly, sales are projected to continue this downward trend to 3.01 billion in 2025 and further to 2.83 billion, 2.65 billion, and 2.47 billion by 2026, 2027, and 2028 respectively. This reflects consistent annual decreases, leading to a compounded annual growth rate (CAGR) of -5.5% over this period.
Future trends to watch for include:
- Advancements in alternative treatments impacting traditional medicine sales.
- Potential regulatory changes influencing market dynamics.
- Increasing prevalence of preventive healthcare potentially reducing demand.
